C'est l'atorvastatine, un réducteur de cholestérol, qui coûte le plus à l'Inami.
Lisez l'article complet ici.
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Followers
Blog Archive
-
▼
2009
(762)
-
▼
October
(166)
-
▼
Oct 02
(8)
- Meer dan helft van baby's zal 100 jaar worden
- Fedis: "Milquet se trompe !"
- Les plus prescrits, les plus coûteux
- L’Olivier balise la bonne gouvernance
- Hausse modérée du chômage en Belgique
- Boeren lopen op hun tandvlees
- Régime strict pour l'administration wallonne
- Dix ans de vie de plus pour trois réacteurs
-
▼
Oct 02
(8)
-
▼
October
(166)
About Me
- Brieuc Van Damme
- I am a young economist at the Itinera Institute, a Brussels based think-tank for sustained economic growth and social protection, and an independent consultant. Since September 2010 I teach "The Contemporary American Economy" class of the M.A. Program in American Studies at the University of Antwerp. I hold degrees in economics from the KULeuven and the College of Europe, and I am an IHS (George Mason University, Virginia) alumnus. My areas of interest (and expertise?) are the political economy in general, and social security systems and healthcare economics in particular. I publish, give lectures and participate in debates in professional and policy circles, as well as in the media.
No comments:
Post a Comment